Clinical Trial Update: Six-months Versus Nine-months ATT for Ocular TB [Phase 4]

View source ↗

Summary

Completed Phase 4 trial comparing six-month versus nine-month anti-tuberculosis therapy durations for ocular tuberculosis, evaluating conditions such as uveitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroiditis
• Retinal Vasculitis
• Tuberculosis
• Uveitis

Drugs mentioned

• Ethambutol (ethambutol)
• ISONIAZID (ISONIAZID)
• Pyrazinamide (pyrazinamide)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: L.V. Prasad Eye Institute | Conditions: Tuberculosis (TB), Uveitis | Phase 4 | Status: COMPLETED